GlassScriptPhysician profile
Terry Spark Corwin
NPI 1912954744
$1,876.53
in general payments reported to CMS, 2019-2025
25 companies · $198 in 2025
The $198 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $158 · 2020: $121 · 2021: $578 · 2022: $424 · 2023: $287 · 2024: $110 · 2025: $198.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $596.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $595.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $279.57 | 2021-2023 | Botox |
| Rochester Medical Corporation | $210.13 | 2020-2022 | |
| Allergan, INC. | $194.15 | 2021-2022 | |
| Pfizer INC. | $189.32 | 2021-2025 | |
| Astellas Pharma US INC | $119.74 | 2020-2023 | Xtandi, Myrbetriq |
| Olympus America INC. | $117.02 | 2019 | |
| Boston Scientific Corporation | $110.35 | 2019-2022 | |
| Urogen Pharma, INC. | $101.19 | 2021 | |
| Myriad Genetic Laboratories, INC. | $85.75 | 2024 | Prolaris |
| Janssen Scientific Affairs, LLC | $76.93 | 2025 | |
| 180 Medical, INC. | $63.66 | 2022 | |
| Progenics Pharmaceuticals, INC. | $44.85 | 2023 | Pylarify |
| Urovant Sciences INC | $39.83 | 2021-2022 | |
| Endo Pharmaceuticals INC. | $39.12 | 2021 | |
| Convatec INC. | $34.34 | 2021-2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ambu INC. | $25.62 | 2025 | |
| Hollister Incorporated | $25.09 | 2021 | |
| Innovation Technologies INC | $24.66 | 2024 | Irrisept |
| Photocure INC | $21.66 | 2023 | Cysview |
| Antares Pharma, INC. | $19.51 | 2021 | |
| Procept Biorobotics Corporation | $15.08 | 2021 | |
| Profound Medical Corp. | $14.48 | 2021 | |
| Axonics, INC. | $12.22 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $11.16 | 2019 | |
| Travere Therapeutics, INC. | $1.10 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terry Corwin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.